Giant Cell Tumor of Bone

Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone

Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Giant Cell Tumor of Bone Surgery

LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas

PROMIS and Mobility Evaluation in Sarcoma Patients

Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone

Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study

Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004

A Study to Evaluate the Efficacy and Safety of Narlumosbart (JMT103) in Patients With Giant Cell Tumor of Bone

Zoledronic Acid-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Bone Tumor After Intralesional Curettage

Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone

Efficacy and Safety of JMT103 in Patients With Giant Cell Tumor of Bone

Study of Denosumab in Subjects With Giant Cell Tumor of Bone

A Real-world Study on Patients of Unresectable Giant Cell Tumor of Bone

Giant Cell Tumor of the Bone in Young Patients

Trial of Dasatinib in Advanced Sarcomas

Safety and Efficacy of Post-operative Denosumab Strategy for Giant Cell Tumor of Bone Treatment in China

Characteristics and Mechanism of Denosumab-treated Giant Cell Tumor of Bone

Giant Cell Tumor of the Extremities Treated With Surgery and/or Medical Treatment

Adjuvant Zoledronic Acid in High Risk Giant Cell Tumour of Bone (GCT)